---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-067810"
form_type: "8-K"
ticker: "FRMM"
cik: "0001690080"
company_name: "FORUM MARKETS Inc"
filed_at: "2023-08-15T23:59:59+00:00"
generated_at: "2026-06-11T09:28:53.271901+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# 180 Life Sciences closes $3M public offering of 4.6M shares and warrants at $0.65

## Summary
- Offering of 4,615,385 shares (or equivalents) and warrants to purchase 4,615,385 shares at $0.65 per unit.
- Gross proceeds ~$3M; net proceeds ~$2.6M after placement agent fees and expenses.
- Proceeds to fund R&D and marketing authorization application for Dupuytren's Contracture in UK and possibly US.
- Existing warrants for 4,448,713 shares amended: exercise price reduced from prior level to $0.83.
- Placement agent A.G.P./Alliance Global Partners; 90-day lock-up for directors and officers.

## SEC filing metadata
- accession: 0001213900-23-067810
- form_type: 8-K
- ticker: FRMM
- cik: 0001690080
- company_name: FORUM MARKETS Inc
- filed_at: 2023-08-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1690080/000121390023067810/0001213900-23-067810-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1690080/000121390023067810/ea183547-8k_180life.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-067810
- JSON: https://secwatch.observer/filing/0001213900-23-067810.json
- Plain text: https://secwatch.observer/filing/0001213900-23-067810.txt

## Key facts
- Material Agreements
  FORUM MARKETS Inc entered into Placement Agency Agreement with A.G.P./Alliance Global Partners (effective 2023-08-09).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: A.G.P./Alliance Global Partners
  - Effective: 2023-08-09
  source text: On August 9, 2023, the Company also entered into a placement agency agreement (the “ Placement Agency Agreement ”) with A.G.P./Alliance Global Partners (the “ Placement Agent ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1690080/000121390023067810/0001213900-23-067810-index.htm
- Material Agreements
  FORUM MARKETS Inc amended Warrant Amendment Agreement with the Institutional Investor (effective 2023-08-09).
  - Action: amendment
  - Counterparty: the Institutional Investor
  - Effective: 2023-08-09
  source text: In connection with the Offering, the Company entered into a warrant amendment agreement (the “ Warrant Amendment Agreement ”), dated August 9, 2023, with the Institutional Investor, whereby the Company agreed to amend the following existing warrants held by such Institutional Investor
  evidence_url: https://www.sec.gov/Archives/edgar/data/1690080/000121390023067810/0001213900-23-067810-index.htm
- Material Agreements
  FORUM MARKETS Inc entered into Purchase Agreement with a certain institutional investor valued at approximately $3.0 million (effective 2023-08-09).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: a certain institutional investor
  - Value: approximately $3.0 million
  - Effective: 2023-08-09
  source text: On August 9, 2023, 180 Life Sciences Corp., a Delaware corporation (the “ Company ”), entered into a securities purchase agreement (the “ Purchase Agreement ”) with a certain institutional investor (the “ Institutional Investor ”) and agreed to issue and sell to certain purchasers, including the Institutional Investor, in a registered public offering (the “ Offering ”), an aggregate of: (i) 666,925 shares (the “ Shares ”) of the Company’s common stock, $0.0001 par value (the “ Common Stock ”), at a price of $0.65 per share
  evidence_url: https://www.sec.gov/Archives/edgar/data/1690080/000121390023067810/0001213900-23-067810-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.